Dr. Mark Kiel MD, PhD, is the Founder and CSO of Genomenon. He practiced as a molecular pathologist at The University of Michigan and has extensive experience in genomic analysis and the clinical application of genomics.
This website uses cookies to improve your experience. while on our website, serve personalized content, provide social media features and to optimize our traffic. By continuing to browse the site you are agreeing to our use of cookies. AcceptRejectRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
